Posted by Michael Wonder on 18 Jan 2021
SMC - January 2021 decisions
18 January 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice accepting five new medicines.
Daratumumab (Darzalex) was accepted for the treatment of adult patients with newly diagnosed multiple myeloma who are eligible for autologous stem cell transplant.
